Daniela Schmitt

About

Daniela Schmitt is a leading researcher in the field of stereotactic radiosurgery, with a particular focus on the treatment of brain metastases using advanced robotic systems. Her work centers on optimizing treatment planning and imaging protocols to improve patient outcomes in radiation oncology. Schmitt’s major contributions include the CYBER-SPACE trial, a single-center prospective randomized study that compared robotic radiosurgery outcomes for brain metastases diagnosed with different MRI sequences (SPACE vs. MPRAGE), which has garnered 11 citations and provides critical guidance for clinical imaging selection. She has also advanced the field by evaluating the InCise2 multileaf collimator (MLC) for the CyberKnife M6 system, demonstrating its efficacy in treating brain metastases with high precision, a study cited 7 times. Additionally, Schmitt has validated 4D dose calculation algorithms using Calypso motion tracking and polymer gel dosimetry, enhancing the accuracy of dose delivery in moving targets. Her research, though early in its citation impact, is foundational for refining radiosurgery techniques, making her a notable figure in the intersection of medical physics and clinical oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   Robotic Radiosurgery for Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence (CYBER-SPACE)—A Single-Center Prospective Randomized Trial

   11 citations · 2018
2. 2
   Treatment planning for MLC based robotic radiosurgery for brain metastases: plan comparison with circular fields and suggestions for planning strategies

   7 citations · 2017
3. 3
   Validation of 4D dose calculation using an independent motion monitoring by the calypso tracking system and 3D polymer gel dosimetry

   3 citations · 2017

Key Collaborators

Contact & Links